在光学相干断层扫描引导下植入生物可吸收支架治疗冠状动脉分叉处支架内再狭窄的挑战性治疗 - Suppr

Suppr

超能文献

Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.

作者信息

Zuk Grzegorz, Ciecwierz Dariusz, Drewla Piotr, Gruchała Marcin, Gutiérrez-Chico Juan Luis, Jaguszewski Milosz

机构信息

Interventional Cardiology, 1st Department of Cardiology, University Clinical Center, Gdansk, Poland.

Punta de Europa University Hospital, Algeciras (Cádiz), Spain.

出版信息

Cardiol J. 2019;26(3):304-306. doi: 10.5603/CJ.2019.0063.

DOI:10.5603/CJ.2019.0063

PMID:31246271

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8086676/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3441/8086676/117feba7cca0/cardj-26-3-304f1.jpg

相似文献

Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.在光学相干断层扫描引导下植入生物可吸收支架治疗冠状动脉分叉处支架内再狭窄的挑战性治疗

Cardiol J. 2019;26(3):304-306. doi: 10.5603/CJ.2019.0063.

Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.生物可吸收血管支架用于治疗严重钙化弥漫性病变血管中的支架内再狭窄和分叉病变的可行性及疗效。

JACC Cardiovasc Interv. 2014 May;7(5):e45-6. doi: 10.1016/j.jcin.2013.08.018. Epub 2014 Apr 16.

Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.使用生物可吸收血管支架治疗支架内再狭窄后的晚期支架血栓形成。

Coron Artery Dis. 2016 Dec;27(8):709-710. doi: 10.1097/MCA.0000000000000405.

Subacute thrombosis of a bioresorbable vascular scaffold implanted for recurrent in-stent restenosis.用于复发性支架内再狭窄而植入的生物可吸收血管支架的亚急性血栓形成。

EuroIntervention. 2015 Nov;11(7):780. doi: 10.4244/EIJY14M10_07.

A broken promise: 4-year optical coherence tomography follow-up of a bioresorbable vascular scaffold.一个破灭的承诺：生物可吸收血管支架的4年光学相干断层扫描随访

J Cardiovasc Med (Hagerstown). 2020 May;21(5):398-400. doi: 10.2459/JCM.0000000000000942.

Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation.生物可吸收血管支架再狭窄：血管内成像评估

J Cardiovasc Med (Hagerstown). 2016 Dec;17 Suppl 2:e132-e135. doi: 10.2459/JCM.0000000000000337.

Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold.镁生物可吸收支架植入15个月后出现严重局灶性再狭窄。

Acta Cardiol. 2020 Feb;75(1):85-86. doi: 10.1080/00015385.2018.1548109. Epub 2019 Feb 8.

Migrated remnant bioresorbable scaffolds in a left main bifurcation lesion: Insights from optical coherence tomography.左主干分叉病变中移位的残余生物可吸收支架：光学相干断层扫描的见解

Cardiol J. 2020;27(2):208-209. doi: 10.5603/CJ.2020.0047.

Severe Neointimal Hyperplasia of Neoplastic Carina Following Bioresorbable Scaffold Implantation Using T-Stenting and Small Protrusion Technique: Insights From Optical Frequency Domain Imaging.使用T型支架和小突出技术植入生物可吸收支架后肿瘤隆突处的严重新生内膜增生：来自光学频域成像的见解

JACC Cardiovasc Interv. 2015 Nov;8(13):e207-9. doi: 10.1016/j.jcin.2015.05.031. Epub 2015 Oct 14.

Very early in-stent neoatherosclerosis assessed by optical coherence tomography.通过光学相干断层扫描评估的极早期支架内新生动脉粥样硬化

Int J Cardiovasc Imaging. 2019 Oct;35(10):1793-1794. doi: 10.1007/s10554-019-01642-5. Epub 2019 Jun 7.

本文引用的文献

Sequential Proximal Optimizing Technique in Provisional Bifurcation Stenting With Everolimus-Eluting Bioresorbable Vascular Scaffold: Fractal Coronary Bifurcation Bench for Comparative Test Between Absorb and XIENCE Xpedition.序贯近段优化技术在雷帕霉素洗脱可吸收血管支架治疗分叉病变中的应用：用于比较 Absorb 和 XIENCE Xpedition 的分叉冠脉支架分岔比对实验台

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1397-406. doi: 10.1016/j.jcin.2016.04.021.

A novel approach to treat in-stent restenosis: 6- and 12-month results using the everolimus-eluting bioresorbable vascular scaffold.一种治疗支架内再狭窄的新方法：使用依维莫司洗脱的生物可吸收血管支架的 6 个月和 12 个月结果。

EuroIntervention. 2016 Apr 20;11(13):1479-86. doi: 10.4244/EIJV11I13A287.

Long-Term Clinical Outcomes After Bioresorbable Vascular Scaffold Implantation for the Treatment of Coronary In-Stent Restenosis: A Multicenter Italian Experience.生物可吸收血管支架治疗冠状动脉支架内再狭窄的长期临床结果：意大利多中心经验。

Circ Cardiovasc Interv. 2016 Apr;9(4):e003148. doi: 10.1161/CIRCINTERVENTIONS.115.003148.

An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition).两种可生物吸收药物洗脱冠状动脉支架（Absorb 和 DESolve）与一种持久金属药物洗脱支架（ML8/Xpedition）的独立体外对比研究。

EuroIntervention. 2015 May;11(1):60-7. doi: 10.4244/EIJY15M02_03.

Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.生物可吸收血管支架治疗支架内再狭窄：光学相干断层成像的见解。

Can J Cardiol. 2015 Mar;31(3):255-9. doi: 10.1016/j.cjca.2014.11.017. Epub 2014 Nov 22.

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.生物可吸收依维莫司洗脱支架与金属依维莫司洗脱支架治疗初发原生冠状动脉病变所致缺血性心脏病的比较（ABSORB II）：一项随机对照临床试验的临床和操作次要终点 1 年中期分析。

Lancet. 2015 Jan 3;385(9962):43-54. doi: 10.1016/S0140-6736(14)61455-0. Epub 2014 Sep 14.

Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies.冠状动脉分叉处可吸收依维莫司洗脱生物可吸收支架：关于植入、分支扩张及后扩张策略的实验台研究

EuroIntervention. 2015 Feb;10(10):1169-77. doi: 10.4244/EIJY14M05_08.

Bioresorbable drug-eluting magnesium-alloy scaffold for treatment of coronary artery disease.生物可吸收药物洗脱镁合金支架治疗冠状动脉疾病。

Int J Mol Sci. 2013 Dec 16;14(12):24492-500. doi: 10.3390/ijms141224492.

A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.一种新一代生物可吸收冠状动脉支架系统：从实验室到首次临床评估：6 个月和 12 个月的临床和多模态影像学结果。

JACC Cardiovasc Interv. 2014 Jan;7(1):89-99. doi: 10.1016/j.jcin.2013.07.007. Epub 2013 Oct 16.

Incidence and short-term clinical outcomes of small side branch occlusion after implantation of an everolimus-eluting bioresorbable vascular scaffold: an interim report of 435 patients in the ABSORB-EXTEND single-arm trial in comparison with an everolimus-eluting metallic stent in the SPIRIT first and II trials.在 ABSORB-EXTEND 单臂试验中，435 例患者接受依维莫司洗脱生物可吸收血管支架治疗后小分支闭塞的发生率及短期临床结局：与 SPIRIT 试验 I 和 II 中依维莫司洗脱金属支架的比较。

JACC Cardiovasc Interv. 2013 Mar;6(3):247-57. doi: 10.1016/j.jcin.2012.10.013.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验